Experts meet on latest advancements in TB research

TweetThe international “TB Vaccines for the World” conference was held this week, bringing together international experts on tuberculosis research for three days in Orlando, Florida. Mycobacterium tuberculosis infects one-in-three people on the earth, resulting in seven to eight million cases … Read More »

Filed in Vaccine Development | Tagged | Leave a comment

Oxford Emergent Tuberculosis Consortium presents at Power of Vaccines event

TweetAdam Stoten, the deputy general manager of the Oxford Emergent Tuberculosis Consortium, recently made a presentation on the progress of new tuberculosis vaccine candidates at the Power of Vaccines symposium. Stoten said that while there has been major progress made … Read More »

Filed in Medical Countermeasures, Vaccine Development | Tagged | Leave a comment

Vaccination against 2009 H1N1 protects against multiple strains

TweetResearchers have determined that vaccination against the pandemic 2009 H1N1 vaccine can generate antibodies against other influenza virus strains as well, including H3N2 and H5N1. The new discovery, combined with a 2011 finding that people infected with pandemic 2009 H1N1 … Read More »

Filed in Vaccine Development | Tagged | Leave a comment

Non-profit teams with mining company for TB vaccine trials

TweetAeras, a non-profit organization with 12 tuberculosis vaccine candidates, has agreed in principle to a deal with Anglo American to make its Southern African mines available for vaccination trials. TB rates are close to the highest in the world in … Read More »

Filed in Africa, Vaccine Development | Tagged | 3 Comments

Scientists create malaria vaccine from algae

TweetBiologists at the University of California – San Diego have created a genetically-engineered algae that produces possible candidates for a malaria vaccine. If such a procedure is effective on a large scale, the achievement could lead to the inexpensive manufacturing … Read More »

Filed in Vaccine Development | Tagged | Leave a comment

More News Headlines

Profectus BioSciences receives $5.6M grant for Nipah/Hendra vaccine

Phase I enrollment for A/H5N1 influenza vaccine trial begins

Scientists developing new methods to identify vaccine components

Crowd-sourcing game could be gateway to disease diagnosis